Electropharmacology Inc

CTD Holdings is a holding company formed in 2000 to acquire, create and invest in companies that will develop, market and sell products containing cyclodextrins. The company was originally organized as Cyclodextrin Technologies Development, a seller of cyclodextrins and related products to the food, pharmaceutical and other industries. Cyclodextrins are molecules that bring together 'oily' materials and water and have potential applications anywhere 'oily substances' and water must be used together. The company has worked with clients for more than 11 years to develop many cyclodextrin-based applications in a variety of areas, such as proteomics, nanotechnology, pharmaceuticals, foods and environmental clean-up. At the end of 1999, CTD had more than 4000 patents in its cyclodextrin patent database. CTD Holdings is headquartered in High Springs, Fla.

Coastal Laboratories, with ten locations in Northeast Florida, offers patients a comfortable environment and state-of-the-art technology for their medical needs. With a focus on providing top-notch care, Coastal Laboratories ensures that patients receive the best possible experience during their visits. Generated from their website's infomation

Hemispherx Biopharma, is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders. Hemispherx s flagship products include Alferon N Injection and the experimental immunotherapeutics/antivirals Ampligen and Oragens. Alferon N Injection is the company's registered trademark for its injectable formulation of Natural Alpha Interferon and is approved by the FDA for a category of STD infection. Alferon N Injection is a highly purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. Alferon LDO is an experimental drug delivery platform for the company s highly purified, natural source alpha interferon. Headquartered in Philadelphia, Hemispherx BioPharma is a publicly owned company that employs nearly 60 people.